Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Advantages of laparoscopic resection for ileocolic Crohn’s disease

Improved outcomes and reduced costs

Abstract

Background

Laparoscopic colorectal procedures are considered to be technically challenging, and there is a lack of consensus regarding the magnitude of their benefits. The laparoscopic approach is generally held to be more expensive. Using a model of a single procedure performed for a single indication (ileocolic resection for Crohn’s disease [CD]), we set out to demonstrate the feasibility of this procedure by determining the conversion rate, documenting the patient benefits, and performing a formal cost analysis.

Methods

Consecutive cases of laparoscopic ileocolic resection for CD were identified (LAP). Case-match methodology identified a series of open laparotomy controls (OPEN) that were matched for five potential confounding criteria: age, gender, diagnosis, type of resection, and date of operation. Pre-, intra-, and postoperative details were gathered. Medical resource utilization was tracked using a standardized database, and all costs were reported in 1999 dollars.

Results

The conversion rate was 5.9%. Resolution of ileus occurred more rapidly in the LAP than in the OPEN group. The time to clears in the LAP group was a median of 0 days (range, 0–4) vs 3.0 days (range, 2–8) in the OPEN group (p=0.0001). Time to regular diet was 2.0 days (range, 1–6) in the LAP group vs 5.0 days (range, 3–12) in the OPEN group (p=0.0001). Length of hospital stay was significantly reduced in the LAP group (4.0 days [range, 2–8], vs 7.0 days [range, 3–14], p=0.0001). The LAP group had significantly lower direct costs ($8684 vs $11,373) and indirect costs ($1358 vs $2349) than the OPEN group (p<0.001). This resulted in total costs of $9895 for LAP vs $13,268 for OPEN (p<0.001).

Conclusion

Laparoscopic ileocolic resection for CD is feasible. There are significant postoperative benefits in terms of resolution of ileus, narcotic use, and hospital stay. This approach translates into cost savings of >$3300 for laparoscopic patients.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bauer JJ, Harris MT, Grumbach NM, Gorfine SR (1996) Laparoscopic-assisted intestinal resection for Crohn’s disease: which patients are good patients? J Clin Gastroenterol 23: 44–46

  2. 2.

    Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. Br Med J 312: 1215–1218

  3. 3.

    Briggs A, Gray A (1998) The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy 3: 233–245

  4. 4.

    Briggs AH, Wonderling DE, Mooney CZ (1997) Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6: 327–340

  5. 5.

    Canin-Endres J, Salky B, Gattorno F, Edye M (1999) Laparoscopically assisted intestinal resection in 88 patients with Crohn’s disease. Surg Endosc 13: 595–599

  6. 6.

    Cuschieri A, Ferreira E, Goh P, Idezuki Y, Maddern G, Marks G, Stiegmann G, Taylor B (1997) Guidelines for conducting economic outcomes studies for endoscopic procedures. Surg Endosc 11: 308–314

  7. 7.

    Efron B, Tibshirani RJ (1998) An introduction to the bootstrap. Chapman & Hall/CRC, New York, pp

  8. 8.

    Gold M, Siegel J, Russel L, Weinstein M (1996) Cost effectiveness in health and Medicine. Oxford University Press, New York, pp

  9. 9.

    Lave L, Pashos CL, Anderson GF, Brailer D, Bubolz T, Conrad D, Freund DA, Fox SM, Keeler E, Lipscomb J (1994) Costing medical care: using Medicare administrative data. Med Care 32: JS77-JS89

  10. 10.

    Liu CD, Rolandelli R, Ashley SW, Evans B, Shin M, McFadden DW (1995) Laparoscopic surgery for inflammatory bowel disease. Am Surg 61: 1054–1056

  11. 11.

    Ludwig K, Milsom JW, Church JM, Fazio VW (1996) Preliminary experience with laparoscopic intestinal surgery for Crohn’s disease. Am J Surg 171: 52–56

  12. 12.

    Reissman P, Salky BA, Edye M, Wexner SD (1996) Laparoscopic surgery in Crohn’s disease: indications and results. Surg Endosc 10: 1201–1204

  13. 13.

    Reissman P, Salky BA, Pfeifer J, Edye M, Jagelman DG, Wexner SD (1996) Laparoscopic surgery in the management of inflammatory bowel disease. Am J Surg 171: 47–51

  14. 14.

    United States Department of Labor Bureau of Labor Statistics. 1999. Table 2: Median usual weekly earnings of full-time wage and salary workers by age, race, hispanic origin, and sex, fourth quarter 1999 averages, not seasonally adjusted. Labor Force Statistics from the Current Population Survey obtained online February 10, 2000 via Bureau of Labor Statistics online (http://www.bls.gov)

  15. 15.

    Wu JS, Birnbaum EH, Kodner IJ, Fry RD, Read TE, Fleshman JW (1997) Laparoscopic-assisted ileocolic resections in patients with Crohn’s disease: are abscesses, phlegmons, or recurrent disease contraindications? Surgery 122: 682–689

  16. 16.

    Young-Fadok TM, Nelson H (2000) Laparoscopic right colectomy: five-step procedure. Dis Colon Rectum 43: 267–273

Download references

Author information

Correspondence to T. M. Young-Fadok.

Additional information

Online publication: 3 April 2001

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Young-Fadok, T.M., Long, K.H., McConnell, E.J. et al. Advantages of laparoscopic resection for ileocolic Crohn’s disease. Surg Endosc 15, 450–454 (2001). https://doi.org/10.1007/s004640080078

Download citation

Key words

  • Ileocolic resection
  • Crohn’s disease
  • Ileus
  • Costs
  • Laparoscopic colectomy
  • Cost analysis